Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

The FDA has accepted Aquestive Therapeutics’ new drug application for its Anaphylm sublingual epinephrine film for treating ...

A novel oral peptide PN-477o with once-daily dosing, high potency and activation of glucagon-like peptide-1 (GLP-1), ...

During June, investigators reported new data that has advanced the treatment landscape for lung cancer, including new FDA ...

FDA issues a complete response letter for oxylanthanum carbonate, a treatment for hyperphosphatemia in patients with chronic ...

Nicox completed the Denali Phase 3 trial for NCX 470, targeting open-angle glaucoma and ocular hypertension. NCX 470 combines ...

The FDA plans to approve selected high-priority drug application submissions in 1 to 2 months rather than 10 to 12.

Late in the evening of June 27, 2025, Senate Republicans released the full text of the latest version of the One Big ...

Rio Arriba County Sheriff Billy Merrifield’s unexpected death from a drug overdose on Easter Sunday has left those closest to him struggling to make sense of how he died and overwhelmed by the ...

President Trump's unconventional approach to clemency has spread hope among federal prisoners and formerly incarcerated people around the United States.

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...